E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects
- PMID: 34097324
- DOI: 10.1002/jgm.3370
E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects
Abstract
Background: The E-cadherin (CDH1) polymorphism has been implicated in the susceptibility to colorectal cancer (CRC). However, the results remain inconclusive. The present meta-analysis aimed to investigate the association between the CDH1-160C/A polymorphism and CRC risk.
Methods: Relevant studies were retrieved by searching PubMed, Web of Science, Google Scholar, the Cochrane Library, Embase, CNKI and Wanfang databases up to 11 March 2021. Pooled odds ratio and 95% confidence interval were calculated using either the fixed- or random-effects model. Quality evaluation was carried out using Newcastle-Ottawa Scale (NOS). A trial sequential analysis (TSA) was conducted to reduce the risk of type I error.
Results: In total, 16 studies from 14 articles with 8699 patients and 8592 controls were included. In general, all studies were of high quality (NOS score higher than 6). Overall, no significant associations between the CDH1 -160C/A polymorphism and CRC risk were detected. In subgroup analysis by ethnicity, source of control, genotyping method and location, significant associations were found between the CDH1-160C/A polymorphism and the risk of CRC in the Caucasians and the hospital-based subgroup. Furthermore, 10 studies with 8019 subjects reported the association between the polymorphism and clinical characteristics in CRC patients, and we found that the CDH1-160C/A polymorphism might show a protective role in the distal CRC subgroup. By TSA, the findings in the present study were based on sufficient evidence in Caucasians, but not in Asians.
Conclusions: This meta-analysis suggests that the CDH1-160C/A polymorphism may be an important protective factor for CRC in Caucasians and a hospital-based subgroup. Moreover, the polymorphism show a protective role in the distal CRC group. However, large and well-designed studies are warranted to validate our findings, especially for Asians.
Keywords: CDH1; colorectal cancer; meta-analysis; polymorphism.
© 2021 John Wiley & Sons, Ltd.
Similar articles
-
Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.Crit Rev Eukaryot Gene Expr. 2017;27(4):347-354. doi: 10.1615/CritRevEukaryotGeneExpr.2017020525. Crit Rev Eukaryot Gene Expr. 2017. PMID: 29283329
-
The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.Clin Exp Med. 2020 Feb;20(1):73-78. doi: 10.1007/s10238-019-00586-3. Epub 2019 Oct 17. Clin Exp Med. 2020. PMID: 31625007
-
The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.Int J Cancer. 2009 Oct 1;125(7):1622-5. doi: 10.1002/ijc.24542. Int J Cancer. 2009. PMID: 19569232
-
TNF-α-308G/A polymorphism and the risk of colorectal cancer: A systematic review and an updated meta-analysis.J BUON. 2018 Nov-Dec;23(6):1616-1624. J BUON. 2018. PMID: 30610785
-
Association of Interleukin-10 Polymorphisms with Susceptibility to Colorectal Cancer and Gastric Cancer: an Updated Meta-analysis Based on 106 Studies.J Gastrointest Cancer. 2022 Dec;53(4):1066-1082. doi: 10.1007/s12029-021-00685-z. Epub 2021 Oct 25. J Gastrointest Cancer. 2022. PMID: 34694592 Review.
Cited by
-
[Influence of E-cadherin methylation on prognosis in children with acute lymphoblastic leukemia].Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jan 15;25(1):46-50. doi: 10.7499/j.issn.1008-8830.2208018. Zhongguo Dang Dai Er Ke Za Zhi. 2023. PMID: 36655663 Free PMC article. Chinese.
-
CDH1 genetic variants and its aberrant expression are the risk factors for colorectal cancer metastasis.BMC Gastroenterol. 2025 Apr 1;25(1):214. doi: 10.1186/s12876-025-03797-z. BMC Gastroenterol. 2025. PMID: 40169954 Free PMC article.
-
The role of the gut microbiota in tumor, immunity, and immunotherapy.Front Immunol. 2024 Jun 5;15:1410928. doi: 10.3389/fimmu.2024.1410928. eCollection 2024. Front Immunol. 2024. PMID: 38903520 Free PMC article. Review.
-
CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness.Anticancer Agents Med Chem. 2025;25(15):1085-1093. doi: 10.2174/0118715206336851241204111721. Anticancer Agents Med Chem. 2025. PMID: 39945249
References
REFERENCES
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
-
- Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev. 2001;10:733-741.
-
- Zhuo Z, Lu H, Zhu J, et al. METTL14 gene polymorphisms confer neuroblastoma susceptibility: an eight-center case-control study. Mol Ther Nucleic Acids. 2020;22:17-26.
-
- Hua RX, Zhuo ZJ, Zhu J, et al. XPG gene polymorphisms contribute to colorectal cancer susceptibility: a two-stage case-control study. J Cancer. 2016;7(12):1731-1739.
-
- Li S, Lin A, Han D, et al. LINC00673 rs11655237 C>T and susceptibility to Wilms tumor: a five-center case-control study. J Gene Med. 2019;21:e3133.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous